These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 7580833

  • 1. HIV-1 soluble antigens induced CD8+ cytotoxic T-cell responses in an immunized individual.
    Achour A, Moukrim Z, Picard O, Bizzini B, Burny A, Zagury D.
    Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):395-400. PubMed ID: 7580833
    [Abstract] [Full Text] [Related]

  • 2. A vaccinia-gp160-based vaccine but not a gp160 protein vaccine elicits anti-gp160 cytotoxic T lymphocytes in some HIV-1 seronegative vaccinees.
    Perales MA, Schwartz DH, Fabry JA, Lieberman J.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep 01; 10(1):27-35. PubMed ID: 7648281
    [Abstract] [Full Text] [Related]

  • 3. An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes.
    Stanhope PE, Liu AY, Pavlat W, Pitha PM, Clements ML, Siliciano RF.
    J Immunol; 1993 May 15; 150(10):4672-86. PubMed ID: 8097759
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of cytotoxic T cell responses to candidate HIV-1 vaccines in HIV-1-uninfected individuals.
    McElrath MJ, Corey L, Greenberg PD.
    AIDS Res Hum Retroviruses; 1994 May 15; 10 Suppl 2():S69-72. PubMed ID: 7865336
    [Abstract] [Full Text] [Related]

  • 5. Studies of the mechanism of cytolysis by HIV-1-specific CD4+ human CTL clones induced by candidate AIDS vaccines.
    Miskovsky EP, Liu AY, Pavlat W, Viveen R, Stanhope PE, Finzi D, Fox WM, Hruban RH, Podack ER, Siliciano RF.
    J Immunol; 1994 Sep 15; 153(6):2787-99. PubMed ID: 7915742
    [Abstract] [Full Text] [Related]

  • 6. Epitope specificity of MHC restricted cytotoxic T lymphocytes induced by candidate HIV-1 vaccine.
    Johnson RP, Hammond SA, Trocha A, Siliciano RF, Walker BD.
    AIDS Res Hum Retroviruses; 1994 Sep 15; 10 Suppl 2():S73-5. PubMed ID: 7532425
    [No Abstract] [Full Text] [Related]

  • 7. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.
    Shirai M, Pendleton CD, Ahlers J, Takeshita T, Newman M, Berzofsky JA.
    J Immunol; 1994 Jan 15; 152(2):549-56. PubMed ID: 8283036
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine.
    Johnson RP, Hammond SA, Trocha A, Siliciano RF, Walker BD.
    J Virol; 1994 May 15; 68(5):3145-53. PubMed ID: 7908700
    [Abstract] [Full Text] [Related]

  • 10. Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein.
    Martinon F, Gras-Masse H, Boutillon C, Chirat F, Deprez B, Guillet JG, Gomard E, Tartar A, Levy JP.
    J Immunol; 1992 Nov 15; 149(10):3416-22. PubMed ID: 1385524
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunization with subunit human immunodeficiency virus vaccine generates stronger T helper cell immunity than natural infection.
    Clerici M, Tacket CO, Via CS, Lucey DR, Muluk SC, Zajac RA, Boswell RN, Berzofsky JA, Shearer GM.
    Eur J Immunol; 1991 Jun 15; 21(6):1345-9. PubMed ID: 1845391
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with rgp120.
    AIDS Vaccine Evaluation Group 022 Protocol Team.
    J Infect Dis; 2001 Feb 15; 183(4):563-70. PubMed ID: 11170981
    [Abstract] [Full Text] [Related]

  • 17. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
    Gómez CE, Abaitua F, Rodríguez D, Esteban M.
    Virus Res; 2004 Sep 15; 105(1):11-22. PubMed ID: 15325077
    [Abstract] [Full Text] [Related]

  • 18. Cytotoxic T lymphocytes specific for the synthetic VEINCTR peptide, a sequence found within the Fas molecule and env gp120 in the blood of HIV-1 seropositive individuals.
    Moukrim Z, Achour A.
    Cell Mol Biol (Noisy-le-grand); 1995 May 15; 41(3):439-44. PubMed ID: 7580839
    [Abstract] [Full Text] [Related]

  • 19. Cytotoxic T lymphocytes specific for HIV-1 gp160 antigen and synthetic P18IIIB peptide in an HLA-A11-immunized individual.
    Achour A, Lemhammedi S, Picard O, M'Bika JP, Zagury JF, Moukrim Z, Willer A, Beix F, Burny A, Zagury D.
    AIDS Res Hum Retroviruses; 1994 Jan 15; 10(1):19-25. PubMed ID: 8179960
    [Abstract] [Full Text] [Related]

  • 20. Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations.
    Ahlers JD, Pendleton CD, Dunlop N, Minassian A, Nara PL, Berzofsky JA.
    J Immunol; 1993 Jun 15; 150(12):5647-65. PubMed ID: 8515081
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.